Study of lactoferrin gene expression in human and mouse adipose tissue, human preadipocytes and mouse 3T3-L1 fibroblasts. Association with adipogenic and inflammatory markers

Journal of Nutritional Biochemistry

Volumn 24, Issue 7, 2013, Pages 1266-1275

  Moreno Navarrete, José María ^a   Serrano, Marta ^a   Sabater, Mònica ^a   Ortega, Francisco ^a   Serino, Matteo ^b   Pueyo, Neus ^a   Luche, Elodie ^b   Waget, Aurelie ^b   Rodriguez Hermosa, José Ignacio ^a   Ricart, Wifredo ^a   Burcelin, Remy ^b   Fernández Real, José Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CHU RANGUEIL   (France)

Author keywords

Adipocytes; Adipose tissue; Lactoferrin; Obesity

Indexed keywords

FAT DROPLET; LACTOFERRIN; ROSIGLITAZONE; BIOLOGICAL MARKER;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PROADIPOCYTE; REAL TIME POLYMERASE CHAIN REACTION; 3T3 CELL LINE; ADIPOCYTE; ADULT; ANIMAL; FEMALE; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED;

MUS;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ADULT; ANIMALS; BIOLOGICAL MARKERS; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION; LACTOFERRIN; MALE; MICE; MIDDLE AGED;

EID: 84879322693     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.10.002     Document Type: Article

References (38)

1. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007, 117:2621-2637.
2. Danforth E. Failure of adipocyte differentiation causes type II diabetes mellitus?. Nat Genet 2000, 26:13.
3. Pietiläinen K.H., Róg T., Seppänen-Laakso T., Virtue S., Gopalacharyulu P., Rodriguez-Cuenca S., et al. Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 2011, 9:e1000623.
4. Ward P.P., Paz E., Conneely O.M. Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci 2005, 62:2540-2548.
5. Moreno-Navarrete J.M., Ortega F.J., Bassols J., Ricart W., Fernández-Real J.M. Decreased circulating lactoferrin in insulin resistance and altered glucose tolerance as a possible marker of neutrophil dysfunction in type 2 diabetes. J Clin Endocrinol Metab 2009, 94:4036-4044.
6. Moreno-Navarrete J.M., Ortega F.J., Ricart W., Fernandez-Real J.M. Lactoferrin increases (172Thr)AMPK phosphorylation and insulin-induced (p473Ser)AKT while impairing adipocyte differentiation. Int J Obes (Lond) 2009, 33:991-1000.
7. Pilvi T.K., Harala S., Korpela R., Mervaala E.M. Effects of high-calcium diets with different whey proteins on weight loss and weight regain in high-fat-fed C57BL/6J mice. Br J Nutr 2009, 102:337-341.
8. Ono T., Murakoshi M., Suzuki N., Iida N., Ohdera M., Iigo M., et al. Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. Br J Nutr 2010, 104:1688-1695.
9. Moreno-Navarrete J.M., Ortega F., Sabater M., Ricart W., Fernández-Real J.M. Proadipogenic effects of lactoferrin in human subcutaneous and visceral preadipocytes. J Nutr Biochem 2011, 2:1143-1149.
10. Zhong J., Krawczyk S.A., Chaerkady R., Huang H., Goel R., Bader J.S., et al. Temporal profiling of the secretome during adipogenesis in humans. J Proteome Res 2010, 9:5228-5238.
11. Grey A., Banovic T., Zhu Q., Watson M., Callon K., Palmano K., et al. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol 2004, 18:2268-2278.
12. Tang L., Wu J.J., Ma Q., Cui T., Andreopoulos F.M., Gil J., et al. Human lactoferrin stimulates skin keratinocyte function and wound re-epithelialization. Br J Dermatol 2010, 163:38-47.
13. Suzuki Y.A., Wong H., Ashida K.Y., Schryvers A.B., Lönnerdal B. The N1 domain of human lactoferrin is required for internalization by caco-2 cells and targeting to the nucleus. Biochemistry 2008, 47:10915-10920.
14. Burcelin R., Crivelli V., Dacosta A., Roy-Tirelli A., Thorens B. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 2002, 282:E834-E842.
15. Cabou C., Campistron G., Marsollier N., Leloup C., Cruciani-Guglielmacci C., Pénicaud L., et al. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 2008, 57:2577-2587.
16. Ortega F.J., Mayas D., Moreno-Navarrete J.M., Catalán V., Gómez-Ambrosi J., Esteve E., et al. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) 2010, 18:13-20.
17. Moreno-Navarrete J.M., Ortega F., Serino M., Luche E., Waget A., Pardo G., et al. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. Int J Obes (Lond) 2012, 36:1442-1449.
18. Moreno-Navarrete J.M., Ortega F.J., Bassols J., Castro A., Ricart W., Fernández-real J.M. Association of circulating lactoferrin concentration and 2 nonsynonymous LTF gene polymorphisms with dyslipidemia in men depends on glucose-tolerance status. Clin Chem 2008, 54:301-309.
19. Dolinková M., Dostálová I., Lacinová Z., Michalský D., Haluzíková D., Mráz M., et al. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol Cell Endocrinol 2008, 291:63-70.
20. Ranganathan G., Unal R., Pokrovskaya I., Yao-Borengasser A., Phanavanh B., Lecka-Czernik B., et al. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 2006, 47:2444-2450.
21. Kouidhi S., Berrhouma R., Rouissi K., Jarboui S., Clerget-Froidevaux M.S., Seugnet I., et al. Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes. Acta Diabetol 2011, [Epub ahead of print].
22. Veilleux A., Blouin K., Rhéaume C., Daris M., Marette A., Tchernof A. Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women. Metabolism 2009, 58:624-631.
23. Jensterle M., Janez A., Mlinar B., Marc J., Prezelj J., Pfeifer M. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. Eur J Endocrinol 2008, 158:793-801.
24. Carvalho E., Kotani K., Peroni O.D., Kahn B.B. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab 2005, 289:E551-E561.
25. Moreno-Navarrete J.M., Ortega F.J., Rodríguez-Hermosa J.I., Sabater M., Pardo G., Ricart W., et al. OCT1 Expression in adipocytes could contribute to increased metformin action in obese subjects. Diabetes 2011, 60:168-176.
26. Lumeng C.N., Deyoung S.M., Saltiel A.R. Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 2007, 292:E166-E174.
27. Constant V.A., Gagnon A., Landry A., Sorisky A. Macrophage conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 2006, 49:1402-1411.
28. Gandotra S., Le Dour C., Bottomley W., Cervera P., Giral P., Reznik Y., et al. Perilipin deficiency and autosomal dominant partial lipodystrophy. N Engl J Med 2011, 364:740-748.
29. Nian Z., Sun Z., Yu L., Toh S.Y., Sang J., Li P. Fat-specific protein 27 undergoes ubiquitin-dependent degradation regulated by triacylglycerol synthesis and lipid droplet formation. J Biol Chem 2010, 285:9604-9615.
30. Ito M., Nagasawa M., Hara T., Ide T., Murakami K. Differential roles of CIDEA and CIDEC in insulin-induced anti-apoptosis and lipid droplet formation in human adipocytes. J Lipid Res 2010, 51:1676-1684.
31. Yagi M., Suzuki N., Takayama T., Arisue M., Kodama T., Yoda Y., et al. Lactoferrin suppress the adipogenic differentiation of MC3T3-G2/PA6 cells. J Oral Sci 2008, 50:419-425.
32. Tang Q.Q., Otto T.C., Lane M.D. CCAAT/enhancerbinding protein β is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci USA 2003, 100:850-855.
33. Zhou Y., Zeng Z., Zhang W., Xiong W., Wu M., Tan Y., et al. Lactotransferrin: a candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer 2008, 123:2065-2072.
34. Naot D., Grey A., Reid I.R., Cornish J. Lactoferrin a novel bone growth factor. Clin Med Res 2005, 3:93-101.
35. Ono T., Morishita S., Fujisaki C., Ohdera M., Murakoshi M., Iida N., et al. Effects of pepsin and trypsin on the anti-adipogenic action of lactoferrin against pre-adipocytes derived from rat mesenteric fat. Br J Nutr 2011, 105:200-211.
36. Yang R.Z., Lee M.J., Hu H., Pray J., Wu H.B., Hansen B.C., et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006, 290:E1253-E1261.
37. Masson O., Chavey C., Dray C., Meulle A., Daviaud D., Quilliot D., et al. LRP1 receptor controls adipogenesis and is up-regulated in human and mouse obese adipose tissue. PLoS One 2009, 4:e7422.
38. Clemente-Postigo M., Queipo-Ortuño M.I., Fernandez-Garcia D., Gomez-Huelgas R., Tinahones F.J., Cardona F. Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One 2011, 6:e24783.